glaxosmithkline plc

China Rules: Drug Giant Faced a Reckoning as China Took Aim at Bribery

China Rules: Drug Giant Faced a Reckoning as China Took Aim at Bribery

Peter Humphrey in Redhill, England. He was arrested in China while working as a corporate investigator for GlaxoSmithKline.
Global Health: Which Big Drug Companies Are Helping the Poor? Here’s the List

Global Health: Which Big Drug Companies Are Helping the Poor? Here’s the List

A scientist works at a GlaxoSmithKline lab in Collegeville, Pa. The pharmaceutical giant retained its place atop the Access to Medicine Index, which measures how companies do at getting drugs and

2 Former Investigators Sue GlaxoSmithKline

The two were investigating a whistle-blower in the pharmaceuticals group in China when they were arrested and convicted of illegally obtaining private records.
The Race for a Zika Vaccine

The Race for a Zika Vaccine

A vaccine for Zika, a disease that is linked to severe birth defects, is being developed by the National Institutes of Health and tested at the University of Maryland.
The Race for a Zika Vaccine

The Race for a Zika Vaccine

A vaccine for Zika, a disease that is linked to severe birth defects, is being developed by the National Institutes of Health and tested at the University of Maryland.
The Race for a Zika Vaccine

The Race for a Zika Vaccine

A vaccine for Zika, a disease that is linked to severe birth defects, is being developed by the National Institutes of Health and tested at the University of Maryland.
Donors and Drug Makers Offer $500 Million to Control Global Epidemics

Donors and Drug Makers Offer $500 Million to Control Global Epidemics

A child born with microcephaly caused by the Zika virus, during an evaluation at Fundação Altino Ventura in Recife, Brazil. A group of prominent donors announced Wednesday that they had raised almost
Donors and Drug Makers Offer $500 Million to Control Global Epidemics

Donors and Drug Makers Offer $500 Million to Control Global Epidemics

A child born with microcephaly caused by the Zika virus, during an evaluation at Fundação Altino Ventura in Recife, Brazil. A group of prominent donors announced Wednesday that they had raised almost
Donors and Drug Makers Offer $500 Million to Control Global Epidemics

Donors and Drug Makers Offer $500 Million to Control Global Epidemics

A child born with microcephaly caused by the Zika virus, during an evaluation at Fundação Altino Ventura in Recife, Brazil. A group of prominent donors announced Wednesday that they had raised almost
Global Health: Vaccine Makers Ranked on Pricing and Research

Global Health: Vaccine Makers Ranked on Pricing and Research

A nurse administrating a flu vaccine shot. The Access to Vaccines Index was released last week. Seasonal influenza is among the top diseases with the most vaccines on the market.
Global Health: Vaccine Makers Ranked on Pricing and Research

Global Health: Vaccine Makers Ranked on Pricing and Research

A nurse administrating a flu vaccine shot. The Access to Vaccines Index was released last week. Seasonal influenza is among the top diseases with the most vaccines on the market.
For Meningitis B Vaccines, Climbing Revenue, and Plenty of Skepticism

For Meningitis B Vaccines, Climbing Revenue, and Plenty of Skepticism

A pharmacist, Jenna Wright, administered the meningitis B vaccine to a student at the University of Oregon in 2015 during a mass clinic set up after an outbreak there.

Breakingviews: Glaxo Could Make a Nice Home for Pfizer’s Consumer Division

It makes sense that Pfizer is considering selling or spinning off its over-the-counter unit. It would also make sense for GlaxoSmithKline to make an offer.
GlaxoSmithKline and Pfizer to Merge Consumer Health Units

GlaxoSmithKline and Pfizer to Merge Consumer Health Units

GlaxoSmithKline’s headquarters in London. It will own 68 percent of the new joint venture, with Pfizer, based in New York, holding the rest.
GlaxoSmithKline and Pfizer to Merge Consumer Health Units

GlaxoSmithKline and Pfizer to Merge Consumer Health Units

GlaxoSmithKline’s headquarters in London. It will own 68 percent of the new joint venture, with Pfizer, based in New York, holding the rest.
GlaxoSmithKline and Pfizer to Merge Consumer Health Units

GlaxoSmithKline and Pfizer to Merge Consumer Health Units

GlaxoSmithKline’s headquarters in London. It will own 68 percent of the new joint venture, with Pfizer, based in New York, holding the rest.